Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
| Acorda Therapeutics Announces Filing of Patent Extension Applications for ... - MarketWatch (press release) |
|
|
|
MarketWatch (press release)AMPYRA is contraindicated in patients with moderate or severe renal impairment (CrClless-than or equal to 50 mL/min); the risk of seizures in patients with ... read more |
Professional dialysis recruitment

